Health Care: Drugs

Alexza Pharmaceuticals Inc. (ALXA: NASDAQ)

$4.16 -0.01 | -0.24%
04/16/14 - 12:23 PM ET
Company Income Statement
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Sales 47.84M 4.07M 5.66M 42.88M
Cost of Sales 6.81M 0.00 0.00 0.00
Gross Operating Profit 41.03M 4.07M 5.66M 42.88M
Selling, General, and Administrative Expenses 15.78M 11.09M 11.77M 14.00M
Research & Development 19.08M 21.85M 28.26M 33.53M
Operating Income before D & A (EBITDA) 6.17M -28.87M -34.37M -4.65M
Depreciation & Amortization 4.40M 4.78M 5.24M 5.04M
Interest Income 0.00 420.00K 26.00K 35.00K
Other Income - Net -39.89M 1.90M -4.00M 4.77M
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) -38.12M -31.34M -43.58M -4.88M
Interest Expense 1.50M 1.43M 2.19M 1.63M
Pre-Tax Income -39.62M -32.76M -45.77M -6.52M
Income Taxes 0.00 0.00 0.00 0.00
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations -39.62M -27.98M -40.53M 1.48M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations -39.62M -27.98M -40.53M 1.48M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -39.62M -27.98M -40.53M -1.48M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-39.62M -27.98M -40.53M 1.48M
Preferred Dividends
Net Income Available To Common -39.62M -27.98M -40.53M 1.48M
Basic EPS from Continuing Ops. -2.38 -2.24 -5.97 0.27
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations -2.38 -2.24 -5.97 0.27
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 -0.03 -0.57
Basic EPS, Total -2.38 -2.24 -6.00 -0.30
Basic Normalized Net Income/Share -2.38 -2.24 -5.97 0.27
EPS fr Continuing Ops. -2.38 -2.24 -5.97 0.27
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. -2.38 -2.24 -5.97 0.27
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 -0.03 -0.57
EPS, Total -2.38 -2.24 -6.00 -0.30
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-2.38 -2.24 -5.97 0.27
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with ALXA

Latest ALXA Headlines from TheStreet

More Financial News for ALXA

Press Releases for ALXA

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter